InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Kosaraju Sridhar, 董事. Officer active across 2 companies, notably 10x Genomics, Inc.. Aggregated, 34 disclosures have been logged. Split: 0 buy · 8 sells. Total volume traded: €650k. Activity tracked since 24 May 2021. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kosaraju Sridhar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报34 总计
8,829 股0Class A Common StockSEC:0001610717-26-000191:0
15,357 股0Class A Common StockSEC:0001610717-25-000167:0
46,575 股Common StockSEC:0000950170-25-050475:0
4,233 股0Common StockSEC:0001444380-25-000004:0
2,817 股0Common StockSEC:0001610717-24-000499:0
1,870 股0Common StockSEC:0001610717-24-000382:0
8,649 股0Class A Common StockSEC:0001610717-24-000329:0
19,169 股0Common StockSEC:0001610717-24-000266:0
1,090 股0Common StockSEC:0001610717-24-000203:0
731 股0Common StockSEC:0001610717-24-000005:0
819 股0Common StockSEC:0001610717-23-000305:0
619 股0Common StockSEC:0001610717-23-000198:0
1,865 股0Class A Common StockSEC:0001610717-23-000172:0
6,754 股0Common StockSEC:0001610717-23-000076:0
435 股0Common StockSEC:0001140361-23-016269:0
397 股0Common StockSEC:0001567619-23-000253:0
337 股0Common StockSEC:0001567619-22-018222:0
10,000 股@ US$11.487.3% 占其流量Class A Common StockSEC:0001567619-22-017560:0
331 股0Common StockSEC:0001567619-22-013691:0
2,120 股0Class A Common StockSEC:0001567619-22-013118:0
4,155 股0Common StockSEC:0001567619-22-011890:0
15,000 股@ US$11.480.0079% mcap11.3% 占其流量Class A Common StockSEC:0001567619-22-011125:0
190 股0Common StockSEC:0001567619-22-008043:0
169 股0Common StockSEC:0001567619-22-000345:0
1,500 股@ US$150.379321.4% 占其流量Class A Common StockSEC:0001567619-22-000372:0
34 条申报中的 25 条
About Kosaraju Sridhar
Kosaraju Sridhar is an Administrateur at NEVRO CORP and 10x Genomics, Inc. There are 34 filings in total, and across the 34 sampled filings the total sell amount is EUR 649986, with filings dated from 2021-05-26 to 2026-06-08 and the most frequent transaction nature listed as Attribution.
